AI Custom Medium Development Service Featured in Various Media
The “AI Custom Media Development Service,” a joint service with Shimadzu Corporation and Shimadzu Diagnostics Corporation announced on February 19, 2026, was covered by various media outlets including Nikkei, Nikkei Biotech, and Mynavi News TECH+.
Media Coverage List
- Nikkei (Digital Edition)
- Nikkei (Kyoto Edition)
- Nikkei (Industry Section)
- Nikkei Biotech
- Mynavi News TECH+
- Yakuji Nippo
- Dempa Shimbun Digital
- Nikkei Biotech
- CTIWEB
- TBS NEWS DIG
- Otakuma Keizai Shimbun
- NIKKEI COMPASS
- Toremaga News
- RBBTODAY
- Jiji.com
- Niconico News
- Toyo Keizai Online
- Asahi Shimbun Digital Magazine &
- BtoB Platform Industry Channel
- Jiji Medical
- Infoseek News
- SEOTOOLS
- JBpress
- STRAIGHT PRESS
- PRESIDENT Online
- NewsPicks
- Nifty News
- @DIME
- Mapion News
- Sankei News
- Zaikei Shimbun
- Mainichi Shimbun Digital
- Nikkan Kogyo Shimbun Digital Edition
- Jordan News!
Related Articles
Won Grand Prix in the 7th IP BASE AWARD Startup Category Hosted by the Japan Patent Office
On March 3, 2026, Epistra Inc. won the Grand Prix in the startup category at the '7th IP BASE AWARD' ceremony hosted by the Japan Patent Office.
Jikkenigaku Special Issue 'AI and Data-Driven Drug Discovery Research' Published — CTO Tsuzuki Authors Chapter on AI-Driven Drug Target Discovery
In 'Jikkenigaku Special Issue: AI and Data-Driven Drug Discovery Research' published by Yodosha, our CTO Taku Tsuzuki authored a chapter on AI-driven knowledge mining for drug target discovery.
Speaking Engagement: Delivered Keynote at the 10th Cell Manufacturing Kotozukuri Symposium
On March 4, 2026, CEO Yosuke Ozawa delivered a keynote speech on optimizing cell manufacturing processes using AI and robotics at the '10th Cell Manufacturing Kotozukuri Symposium' hosted by Osaka University.